These authors firstly demonstrated that human peripheral blood mononuclear cells (hPBMCs) and Namalwa tumor cells (Burkitt’s lymphoma cell line lacking CD200 expression) simultaneously injected in NOD/SCID mice show reduced tumor growth with respect to that observed in mice in the absence of hPBMCs (23, 24). The gene discussed is CD200; the disease is neoplasm.